Expanding and Personalizing Treatment Options for Alcohol Use Disorders Including Pharmacogenomics (R01)
ArchivedNational Institutes of Health
Description
Purpose. Under this Funding Opportunity Announcement (FOA), the National Institute on Alcohol Abuse and Alcoholism (NIAAA) requests research project grants (R01) to study how genetic variation affects responses to medications for the treatment of Alcohol Use Disorders (AUD). Both human and animal studies are encouraged to determine the full range of genetic variation affecting both pharmacodynamic and pharmacokinetic parameters resulting in altered drug efficacy and toxicity. Mechanistic studies using animal models and/or in vitro/ex vivo preparations are also encouraged. Mechanism of Support. This FOA will utilize the R01 grant mechanism. Funds Available and Anticipated Number of Awards. NIAAA has available $2 million in total cost for fiscal year 2011 for this announcement and expects that two to four awards will be made.
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities / Indian housing authorities
- Native American tribal organizations (other than Federally recognized)
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedJun 16, 2010
- ClosesSep 7, 2011
- Program funding$2,000,000
- Expected awards4
- CFDA93.273
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro